• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

ohm20

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 3801-3850 of 6028 result(s).

Board Name	Posts By ohm20	Post Created
CYDY CytoDyn Inc	A side effect of investing in RLFTF (2)	03/05/2021 4:09:03 PM
CYDY CytoDyn Inc	It's a phase 2 trial and it's a gua (11)	03/05/2021 3:58:29 PM
CYDY CytoDyn Inc	Don't make me turn this car around. (6)	03/04/2021 1:50:50 AM
CYDY CytoDyn Inc	Leronlimab and vaccine for RA. It s (2)	03/03/2021 8:53:02 PM
CYDY CytoDyn Inc	With Modi in charge I trust the fig	03/03/2021 8:14:47 PM
CYDY CytoDyn Inc	Since the basis of an EUA is may be (5)	03/03/2021 7:51:07 PM
CYDY CytoDyn Inc	Why are fact checks done? Because f (2)	03/03/2021 5:01:46 PM
CYDY CytoDyn Inc	My wife has RA and will not take th (2)	03/03/2021 4:58:17 PM
CYDY CytoDyn Inc	So I guess I’m always conflicted (2)	03/03/2021 4:53:21 PM
CYDY CytoDyn Inc	I'm guessing you framed that as a q (3)	03/03/2021 4:44:48 PM
CYDY CytoDyn Inc	Do they deserve treatment for said (1)	03/03/2021 2:06:20 PM
CYDY CytoDyn Inc	Ok, anti-vax, anti-abortion. Now ar (7)	03/03/2021 1:34:30 PM
CYDY CytoDyn Inc	First link is about defective mRNA (10)	03/03/2021 12:14:01 PM
CYDY CytoDyn Inc	Nasdaq is looking for anything that (3)	03/03/2021 11:25:05 AM
CYDY CytoDyn Inc	Here is what the SEC considers mate (2)	03/03/2021 2:07:52 AM
CYDY CytoDyn Inc	When we do get results then you'll (3)	03/03/2021 12:04:39 AM
CYDY CytoDyn Inc	I believe it was an Archbishop that (1)	03/02/2021 10:56:23 PM
CYDY CytoDyn Inc	CERC-002 actually targets a differe (1)	03/02/2021 10:54:00 PM
CYDY CytoDyn Inc	The FDA is not out to get us. They (6)	03/02/2021 10:15:35 PM
CYDY CytoDyn Inc	Normy isn't soft bashing. Although (1)	03/02/2021 10:12:22 PM
CYDY CytoDyn Inc	Let the pearl-clutching and panty-t (6)	03/02/2021 9:43:14 PM
CYDY CytoDyn Inc	CERC's drug is anti-TNF only. Which (2)	03/02/2021 9:21:46 PM
CYDY CytoDyn Inc	Back in 2018 there was silence and	03/01/2021 6:00:09 PM
CYDY CytoDyn Inc	Does RLFTF give discounts to invest (1)	03/01/2021 5:04:51 PM
CYDY CytoDyn Inc	It will cost less than having the o (4)	03/01/2021 4:40:49 PM
CYDY CytoDyn Inc	How long can the borrowed shares si (1)	03/01/2021 12:22:00 AM
CYDY CytoDyn Inc	clambottler is heavy into NeuroRX/R (6)	02/28/2021 8:48:21 PM
CYDY CytoDyn Inc	Correct, they'll make more on a $5 (1)	02/28/2021 8:46:02 PM
CYDY CytoDyn Inc	When shorts borrow they're looking	02/28/2021 8:10:11 PM
CYDY CytoDyn Inc	He's been bashing it since he sold	02/28/2021 7:46:22 PM
CYDY CytoDyn Inc	I try to help people out to discove (7)	02/28/2021 8:36:50 AM
CYDY CytoDyn Inc	Unfortunately you haven't shorted s (11)	02/28/2021 7:44:55 AM
CYDY CytoDyn Inc	The big unknown is what deal we hav (2)	02/27/2021 11:33:26 PM
CYDY CytoDyn Inc	The SAEs in CD10 would have include (1)	02/27/2021 11:16:36 PM
CYDY CytoDyn Inc	Still a lot of short shares out. I (1)	02/27/2021 11:04:16 PM
CYDY CytoDyn Inc	I've always thought it would settle (4)	02/27/2021 10:59:27 PM
CYDY CytoDyn Inc	I have been unable to find Dr. Patt (1)	02/26/2021 11:33:04 PM
CYDY CytoDyn Inc	With 66% effectiveness I will be ge (2)	02/26/2021 5:24:56 PM
CYDY CytoDyn Inc	With the current upper level admini (2)	02/26/2021 5:23:04 PM
CYDY CytoDyn Inc	Large position in RLFTF and very sm (1)	02/26/2021 3:35:43 PM
CYDY CytoDyn Inc	Oh I have a feeling EUA is near... (2)	02/26/2021 2:48:35 PM
CYDY CytoDyn Inc	There will never be a cure but ther (3)	02/26/2021 10:45:32 AM
CYDY CytoDyn Inc	perhaps Ohm20 already has this on h (2)	02/26/2021 9:37:28 AM
CYDY CytoDyn Inc	Those are two different metrics. Th (1)	02/26/2021 9:27:03 AM
CYDY CytoDyn Inc	Of course we've seen that. Whatever (2)	02/26/2021 9:14:31 AM
CYDY CytoDyn Inc	ABC has it covered, now we need CBS (3)	02/26/2021 9:03:24 AM
CYDY CytoDyn Inc	Once you have the image uploaded fr	02/26/2021 8:50:25 AM
CYDY CytoDyn Inc	The chart is screwy, it corresponds (1)	02/25/2021 4:14:01 PM
CYDY CytoDyn Inc	Hows sad :( https://stocktwits.com/ (6)	02/25/2021 3:09:01 PM
CYDY CytoDyn Inc	Many seem to be related to the immu	02/25/2021 1:54:07 PM

• Next >

60747686074751607254960724926072480607247360724016072399607239460723826072191607214360720056071918607133860713256071303607130160712866071283607127160712616069879606985860698366068781606872060687186068701606869460684926068476606843460684266068423606842160681256068007606800560678846067835606736960672436067224606720060671626067122606670760666016066488

Recent Articles

• Exploring Trump's Innovative AI Defense Initiative Today
• Transforming Housing in Canada: The Build Canada Homes Initiative
• Federal Initiative to Strengthen Housing Affordability in Canada
• Build Canada Homes: A Revolutionary Step to Affordable Housing
• Elon Musk Addresses Violence Concerns Amid Political Tensions
• Public Perception Contrasts with Trump's Economic Claims
• Apple Reinforces Design Values After Design Team Changes
• Surging Housing Market: Stocks to Watch Amid Interest Shifts
• Alto Neuroscience Investors Alerted to Participate in Case
• Nutex Health Inc. Faces Class Action: Investors Urged to Act
• X Square Robot Secures Investment for Future of Humanoid AI
• Exploring High-Yield Blue Chip Stocks: Opportunities and Risks
• Investigating Securities Violations of Lesaka Technologies, Inc.
• Potential Risks Loom as AI Stock Market Valuations Soar
• Novo Nordisk Investors Urged to Join Class Action for Compensation
• Mark Cuban Defends Steve Ballmer Amid Clippers Controversy
• Build Canada Homes Initiative Set to Revolutionize Housing Market
• Charlie Javice Takes Accountability for $175 Million Fraud Case
• Understanding the Psychological Impact of AI on Users
• Trump Engages TikTok Advocating Accountability for Media
• Understanding Economic Inequality Through Robert Reich's Lens
• Rent Surges in NYC’s Top Neighborhoods Amid Economic Shifts
• Navigating Investor Rights: Semler Scientific Case Update
• Trump Intensifies Rhetoric Against Soros Amid Controversy
• Breast Cancer Antibody Drug Conjugates: Opportunities Ahead
• Important Update for SelectQuote, Inc. Investors on Class Action
• Cornelius D. Jones Joins Prestigious Academy of Authors
• Lantheus Holdings Faces Class Action: Investors Urged to Act
• Hyundai's Supernal Faces Leadership Changes, Future Uncertain
• Larry Ellison: From College Dropout to Tech Titan
• Gold Producers Tackle Emissions with Mixed Results in ESG Metrics
• China's Potential Ban on Flush Door Handles in Cars
• Market Insights: Top 10 Large Cap Stocks Facing Declines
• Crypto Landscape Shifts: Ethereum ETFs Surge Amid Market Changes
• Investigating PACS Group, Inc.: Shareholder Concerns Addressed
• Pomerantz Law Firm Launches Investigation on Freeport-McMoRan
• Quanex Building Products Faces Potential Investor Claims Today
• Geely Automobile Holdings: Investor Concerns and Legal Steps
• MarineMax, Inc. Investors: Key Insights and Updates for HZO
• Matrix Service Company Faces Scrutiny Over Investor Claims
• Pomerantz Law Firm Investigates Potential Securities Fraud by BellRing Brands
• Bumble Inc. Faces Legal Scrutiny Over Potential Securities Violations
• Pomerantz Law Firm Launches Investigation into Agilon Health
• Pomerantz Law Firm Reviews Securities Claims Against Synopsys
• Investor Investigation: Duolingo, Inc. Faces Claims and Trends
• Insperity, Inc. Under Investigation for Possible Securities Fraud
• Class Action Filed Against Dow Inc. by Pomerantz Law Firm
• Concerns Rise as Pomerantz Law Firm Investigates Fluor Corp
• Big Week for Large-Cap Stocks: Top Gainers You Can't Miss
• Celebrating Everlight Solar: Madison's Top Choice in 2025